Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.
- Conditions
- Post-operative Pain
- Interventions
- Procedure: erector spinae plane block (ESP)Drug: DuramorphDrug: RopivacaineDrug: Bupivacaine Injection
- Registration Number
- NCT06114121
- Lead Sponsor
- University of Miami
- Brief Summary
The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- Female
- Target Recruitment
- 100
Not provided
- Adults unable to consent
- BMI>35
- Individuals <18 years of age at time of admission
- Individuals taking anticoagulant medications
- Significant co-morbid disease of pregnancy (including: gestational diabetes and significant abnormal placentation)
- Pre-existing chronic pain or pain disorder diagnosis
- Conversion from neuraxial to general anesthesia
- Prisoners
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description erector spinae plane block Bupivacaine Injection participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block erector spinae plane block erector spinae plane block (ESP) participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block standard of care Bupivacaine Injection participants in this group will receive the standard of care treatment and will be in this group for up to 9 months. erector spinae plane block Ropivacaine participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block standard of care Ropivacaine participants in this group will receive the standard of care treatment and will be in this group for up to 9 months. erector spinae plane block Duramorph participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block standard of care Duramorph participants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
- Primary Outcome Measures
Name Time Method post-operative opioid analgesic medication up to 24 hours measurement (milligrams)
- Secondary Outcome Measures
Name Time Method change in post-operative pain medication by visual analog scale baseline, up to 24 hours Patient administered instrument to indicate pain on a level from 0 to10. (0: no pain. 10: worst imaginable pain)
number of minutes to first use of rescue medication up to 24 hours the number of minutes calculated using the kaplan-meier. Calculated using the number of patients that did not need the rescue analgesic at the start of each day post-surgery, and the number of patients who needed the rescue analgesic.
obstetric quality of recovery scale up to 24 hours responses range from 0-10. zero is strongly agree, strongly disagree.
Trial Locations
- Locations (1)
University of Miami
🇺🇸Miami, Florida, United States